Research ArticleResearch Article
Pegylated Liposomal Doxorubicin as a Single Agent or as Combination Therapy with Carboplatin in Patients with Recurrent or Refractory Epithelial Ovarian Cancer
Keng Shen, Beihua Kong, Yunong Gao, Lingying Wu, Ziting Li, Yile Chen, Mengda Li, Yongliang Gao, Ding Ma and Zhilan Peng
Clinical Oncology and Cancer Research December 2009, 6 (6) 387-393; DOI: https://doi.org/10.1007/s11805-009-0387-1
Keng Shen
1Peking Union Medical College Hospital, Beijing, China.
Beihua Kong
2Shandong University Qilu Hospital, Jinan, Shandong Province, China.
Yunong Gao
3Beijing Oncology Hospital, Beijing, China.
Lingying Wu
4Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing, China.
Ziting Li
5Fudan University Cancer Hospital, Shanghai, China.
Yile Chen
6Hunan Province Oncology Hospital, Changsha, Hunan Province, China.
Mengda Li
7Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong Province, China.
Yongliang Gao
8Zhejiang Province Oncology Hospital, Hangzhou, Zhejiang Province, China.
Ding Ma
9Tongji Hospital of Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hubei Province, China.
Zhilan Peng
10West China Second Hospital of Sichuan University, Chengdu, Sichuan Province.
References
- ↵
- Ries LAG,
- Harkins D,
- Krapcho M, et al.
- Friedman GD,
- Skilling JS,
- Udaltsova NV, et al.
- ↵
- Smith LH,
- Morris CR,
- Yasmeen S, et al.
- ↵
- American Cancer Society
- ↵NCCN Clinical Practice Guidelines in Oncology™. Ovarian Cancer. V.1.2007 http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf. Accessed 01/10/2007.
- ↵
- Parmar MK,
- Ledermann JA,
- Colombo N, et al. ICON and AGO Collaborators
- ↵
- ten Bokkel Huinink W,
- Gore M,
- Carmichael J, et al.
- ↵
- Lund B,
- Hansen OP,
- Theilade K, et al.
- ↵
- Rothenberg ML,
- Liu PY,
- Wilczynski S, et al.
- ↵
- Bajetta E,
- Leo AD,
- Biganzoli L, et al.
- ↵
- Muggia FM,
- Hainsworth JD,
- Jeffers S, et al.
- ↵
- Rose PG,
- Blessing JA,
- Mayer AR, et al.
- ↵
- Gordon AN,
- Fleagle JT,
- Guthrie D, et al.
- ↵
- Drummond DC,
- Meyer O,
- Hong K, et al.
- ↵
- Gabizon A,
- Catane R,
- Uziely B, et al.
- ↵
- Northfelt DW,
- Martin FJ,
- Working P, et al.
- ↵
- Gordon AN,
- Granai CO,
- Rose PG, et al.
- ↵
- Gordon AN,
- Tonda M,
- Sun S, et al.
- ↵
- Ferrero JM,
- Weber B,
- Geay JF, et al.
- ↵
- Pujade-Lauraine E,
- Mahner S,
- Kaern J, et al.
In this issue
Pegylated Liposomal Doxorubicin as a Single Agent or as Combination Therapy with Carboplatin in Patients with Recurrent or Refractory Epithelial Ovarian Cancer
Keng Shen, Beihua Kong, Yunong Gao, Lingying Wu, Ziting Li, Yile Chen, Mengda Li, Yongliang Gao, Ding Ma, Zhilan Peng
Clinical Oncology and Cancer Research Dec 2009, 6 (6) 387-393; DOI: 10.1007/s11805-009-0387-1
Pegylated Liposomal Doxorubicin as a Single Agent or as Combination Therapy with Carboplatin in Patients with Recurrent or Refractory Epithelial Ovarian Cancer
Keng Shen, Beihua Kong, Yunong Gao, Lingying Wu, Ziting Li, Yile Chen, Mengda Li, Yongliang Gao, Ding Ma, Zhilan Peng
Clinical Oncology and Cancer Research Dec 2009, 6 (6) 387-393; DOI: 10.1007/s11805-009-0387-1
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.